Reaktionsgleichung
[CH2:1]([O:3][C:4]([C:6]1([C:15]2[S:16][C:17]([CH2:20]Cl)=[CH:18][CH:19]=2)[CH2:14][C:13]2[C:8](=[CH:9][CH:10]=[CH:11][CH:12]=2)[CH2:7]1)=[O:5])[CH3:2].[CH:22]1([C:25]2[NH:26][C:27]3[C:28]([N:35]=2)=[N:29][C:30]([CH3:34])=[CH:31][C:32]=3[CH3:33])[CH2:24][CH2:23]1>>[CH2:1]([O:3][C:4]([C:6]1([C:15]2[S:16][C:17]([CH2:20][N:35]3[C:28]4=[N:29][C:30]([CH3:34])=[CH:31][C:32]([CH3:33])=[C:27]4[N:26]=[C:25]3[CH:22]3[CH2:24][CH2:23]3)=[CH:18][CH:19]=2)[CH2:14][C:13]2[C:8](=[CH:9][CH:10]=[CH:11][CH:12]=2)[CH2:7]1)=[O:5])[CH3:2]Komponenten
3
Versuchsvorschrift
The product of Example 6, Step 4, above (26), was alkylated as described in Example 1, Step 5, using 2-cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridine (13) to obtain the title compound (29).
Quellen und Nachweise
- ORD-Eintrag
- ord-7474aaa5a7444585a58bef72af5902dc
- Quelldatensatz
- uspto-grants-1998_08
- Patentnummer
- US05789415
Verknüpfte Notizen
Wird geladen…